REFERENCES
- AlSous M W, Bohlega S, AlKawi M Z, Alwatban J, McLean D R. Neurobrucellosis: clinical and neuroimaging correlation. AJNR Am J Neuroradiol 2004; 25: 395–401, [CSA]
- deSeze J, Stojkovic T, Breteau G, Lucas C, Michon-Pasturel U, Gauvrit J Y, Hachulla E, Mounier-Vehier F, Pruvo J P, Leys D, Destee A, Hatron P Y, Vermersch P. Acute myelopathies: clinical, laboratory and outcome profiles in 79 cases. Brain 2001; 124: 1509–1521, [CSA], [CROSSREF]
- Dornand J, Gross A, Lafont V, Liautard J, Oliaro J, Liautard J P. The innate immune response against Brucella in humans. Vet Microbiol 2002; 90: 383–394, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gadient R A, Otten U H. Interleukin-6 (IL-6)—a molecule with both beneficial and destructive potentials. Prog Neurobiol 1997; 52: 379–390, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gruol D L, Nelson T E. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997; 15: 307–339, [PUBMED], [INFOTRIEVE], [CSA]
- Kerr D A, Ayetey H. Immunopathogenesis of acute transverse myelitis. Curr Opin Neurol 2002; 15: 339–347, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kim K K. Idiopathic recurrent transverse myelitis. Arch Neurol 2003; 60: 1290–1294, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kochar D K, Agarwal N, Jain N, Sharma B V, Rastogi A, Meena C B. Clinical profile of neurobrucellosis—a report on 12 cases from Bikaner (north-west India). J Assoc Physicians India 2000; 48: 376–380, [PUBMED], [INFOTRIEVE], [CSA]
- Koussa S, Chemaly R. Neurobrucellosis presenting with diffuse cerebral white matter lesions. Eur Neurol 2003; 50: 121–123, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Krishnan C, Kaplin A I, Deshpande D M, Pardo C A, Kerr D A. Transverse Myelitis: pathogenesis, diagnosis and treatment. Front Biosci 2004; 9: 1483–1499, [PUBMED], [INFOTRIEVE], [CSA]
- Olson T S, Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002; 283: R7–R28, [PUBMED], [INFOTRIEVE], [CSA]
- Pandit L, Rao S. Recurrent myelitis. J Neurol Neurosurg Psychiatry 1996; 60: 336–338, [PUBMED], [INFOTRIEVE], [CSA]
- Pascual J, Combarros O, Polo J M, Berciano J. Localized CNS brucellosis: report of 7 cases. Acta Neurol Scand 1988; 78: 282–289, [PUBMED], [INFOTRIEVE]
- Ransohoff R M, Howe C L, Rodriguez M. Growth factor treatment of demyelinating disease: at last, a leap into the light. Trends Immunol 2002; 23: 512–516, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Seidel G, Pardo C A, Newman-Toker D, Olivi A, Eberhart C G. Neurobrucellosis presenting as leukoencephalopathy: the role of cytotoxic T lymphocytes. Arch Pathol Lab Med 2003; 127: e374–e377, [PUBMED], [INFOTRIEVE]
- Yu X, Kennedy R H, Liu S J. JAK2/STAT3, not ERK1/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes. J Biol Chem 2003; 278: 16304–16309, [PUBMED], [INFOTRIEVE], [CROSSREF]